216 related articles for article (PubMed ID: 22458506)
1. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.
Nicoll-Griffith DA
Expert Opin Drug Discov; 2012 Apr; 7(4):353-66. PubMed ID: 22458506
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteases as potential targets for anti-trypanosomatid drug discovery.
Judice WAS; Ferraz LS; Lopes RM; Vianna LDS; Siqueira FDS; Di Iorio JF; Dalzoto LAM; Trujilho MNR; Santos TDR; Machado MFM; Rodrigues T
Bioorg Med Chem; 2021 Sep; 46():116365. PubMed ID: 34419821
[TBL] [Abstract][Full Text] [Related]
3. Targeting cysteine proteases in trypanosomatid disease drug discovery.
Ferreira LG; Andricopulo AD
Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
[TBL] [Abstract][Full Text] [Related]
4. Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.
Saha A; Pushpa ; Moitra S; Basak D; Brahma S; Mondal D; Molla SH; Samadder A; Nandi S
Curr Med Chem; 2024; 31(16):2135-2169. PubMed ID: 37340748
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of macrocyclic trypanosomal cysteine protease inhibitors.
Chen YT; Lira R; Hansell E; McKerrow JH; Roush WR
Bioorg Med Chem Lett; 2008 Nov; 18(22):5860-3. PubMed ID: 18585034
[TBL] [Abstract][Full Text] [Related]
6. Metal compounds for the treatment of parasitic diseases.
Fricker SP; Mosi RM; Cameron BR; Baird I; Zhu Y; Anastassov V; Cox J; Doyle PS; Hansell E; Lau G; Langille J; Olsen M; Qin L; Skerlj R; Wong RS; Santucci Z; McKerrow JH
J Inorg Biochem; 2008 Oct; 102(10):1839-45. PubMed ID: 18684510
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
Chen YT; Brinen LS; Kerr ID; Hansell E; Doyle PS; McKerrow JH; Roush WR
PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20856868
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
Pereira GAN; da Silva EB; Braga SFP; Leite PG; Martins LC; Vieira RP; Soh WT; Villela FS; Costa FMR; Ray D; de Andrade SF; Brandstetter H; Oliveira RB; Caffrey CR; Machado FS; Ferreira RS
Eur J Med Chem; 2019 Oct; 179():765-778. PubMed ID: 31284086
[TBL] [Abstract][Full Text] [Related]
9. Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors.
Burtoloso AC; de Albuquerque S; Furber M; Gomes JC; Gonçalez C; Kenny PW; Leitão A; Montanari CA; Quilles JC; Ribeiro JF; Rocha JR
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005343. PubMed ID: 28222138
[TBL] [Abstract][Full Text] [Related]
10. Novel cruzain inhibitors for the treatment of Chagas' disease.
Rogers KE; Keränen H; Durrant JD; Ratnam J; Doak A; Arkin MR; McCammon JA
Chem Biol Drug Des; 2012 Sep; 80(3):398-405. PubMed ID: 22613098
[TBL] [Abstract][Full Text] [Related]
11. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
[TBL] [Abstract][Full Text] [Related]
12. Benzimidazole inhibitors of the major cysteine protease of
Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
[No Abstract] [Full Text] [Related]
13. Discovery of Novel Inhibitors of Cruzain Cysteine Protease of
Prates JLB; Lopes JR; Chin CM; Ferreira EI; Dos Santos JL; Scarim CB
Curr Med Chem; 2024; 31(16):2285-2308. PubMed ID: 37888814
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
15. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
Bastos IM; Motta FN; Grellier P; Santana JM
Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
[TBL] [Abstract][Full Text] [Related]
16. Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases.
Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
Curr Top Med Chem; 2021; 21(21):1871-1899. PubMed ID: 33797369
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
[TBL] [Abstract][Full Text] [Related]
18. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes.
Gilbert IH
Biochim Biophys Acta; 2002 Jul; 1587(2-3):249-57. PubMed ID: 12084467
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
